Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-018816

Chief Executive Officer acquired 1,091,299 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Carpenter George C IV Chief Executive Officer 2013-03-27 Option exercise +1,091,299 $0.05 $51,509 1,159,549 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Carpenter George C IV Chief Executive Officer 2013-03-27 Option exercise · Convertible Note −50,000 0 D: show line 2 in the form
Loading xslF345X03/v339978_form4.xml…